Your browser doesn't support javascript.
loading
Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients.
Burstiner, Landen Shane; Owings, Anna H; Royer, Amor; Hreish, Yousef; Johnson, Jeshanah; Barr, Madelyn; Laird, Hannah; Tarugu, Spurthi; Edwards, Kane; Bradley, Lauren; Brar, Himmat; Robinson, Tanya O; Hosseini-Carroll, Pegah; Liu, Julia; Glover, Sarah C.
Affiliation
  • Burstiner LS; Department of Medicine, University of Florida College of Medicine, Jacksonville, FL, USA.
  • Owings AH; Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Davie, FL, USA.
  • Royer A; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Hreish Y; Division of Digestive Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
  • Johnson J; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Barr M; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Laird H; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Tarugu S; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Edwards K; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Bradley L; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Brar H; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Robinson TO; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Hosseini-Carroll P; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Liu J; Division of Digestive Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
  • Glover SC; Division of Digestive Diseases, University of Mississippi Medical Center, Jackson, MS, USA.
Inflamm Bowel Dis ; 29(12): 1847-1853, 2023 Dec 05.
Article in En | MEDLINE | ID: mdl-36808256
This study explores the question of how IBD therapeutic efficacy may vary among racial groups.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Tumor Necrosis Factor Inhibitors Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Tumor Necrosis Factor Inhibitors Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article Affiliation country: